Colistin–glycopeptide combinations against multidrug-resistant Acinetobacter baumannii in a mouse model of pneumonia - Archive ouverte HAL Access content directly
Journal Articles Future Microbiology Year : 2019

Colistin–glycopeptide combinations against multidrug-resistant Acinetobacter baumannii in a mouse model of pneumonia

(1, 2) , (3) , (1, 3) , (2) , (1, 3) , (1, 2) , (1, 3)
1
2
3

Abstract

Aim: To assess the effect of colistin-glycopeptide combination against a multidrug-resistant strain of Acinetobacter baumannii. Materials & methods: We used in vitro procedures (Etest method, checkerboard test and kill-time assays) and a mouse model of a carbapenem-resistant A. baumannii pneumonia. Results: The colistin-teicoplanin combination allowed a 74% increase of the survival in the mouse model within the 4 days following bacterial inoculation as compared with saline or colistin alone (p = 0.06). Concurrently, the colistin-vancomycin combination presented a similar efficacy as compared with saline or colistin alone in the mouse model. Conclusion: According to those preliminary results, using the colistin-teicoplanin combination in therapeutic deadlocks encountered in certain multiresistant A. baumannii pneumonia could be envisaged if the results are confirmed.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02167761 , version 1 (28-06-2019)

Identifiers

Cite

Diane Sanderink, Viviane Cassisa, Rachel Chenouard, Rafael Mahieu, Marie Kempf, et al.. Colistin–glycopeptide combinations against multidrug-resistant Acinetobacter baumannii in a mouse model of pneumonia. Future Microbiology, 2019, 14 (7), pp.581-586. ⟨10.2217/fmb-2019-0022⟩. ⟨inserm-02167761⟩
52 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More